Apotex Health prices upsized IPO at $24 per share

Drug company Apotex Health Corp. has priced its initial public offering at $24 per share.

In its final prospectus, the company says it will issue 54,166,670 shares in the offering that is expected to see gross proceeds total $1.3 billion. That’s more than an earlier plan by the company to sell $1 billion in shares.

Apotex says the offering includes a treasury offering of 35,416,666 shares for gross proceeds of $850 million and a secondary offering by certain shareholders of 18,750,004 shares for $450 million.

The selling shareholders have also granted the underwriters an over-allotment option for up to an additional 8,125,000 shares at the offer price.

The offering is expected to occur on or about June 16, subject to customary closing conditions. The shares traded for $27.05 in early afternoon trading on the Toronto Stock Exchange on an “if, as and when issued” basis Wednesday.

Apotex has a broad portfolio of generic drugs and consumer health products.

The Canadian Press

The Canadian Press is a national news agency headquartered in Toronto and founded in 1917.